check_circleStudy Completed
Bacterial Infection
Bayer Identifier:
Trial_1359
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
Not Available
EU CT Number:
Not Available
Ciprofloxacin (sequential IV/PO, Intravenous/Peroral) in pediatric cystic fibrosis patients with acute pulmonary exacerbation
Trial purpose
Please see attached Study Results Summary below
Key Participants Requirements
Sex
N/AAge
5 - 17 YearsTrial summary
Enrollment Goal
18Trial Dates
August 1992 - August 1994Phase
N/ACould I Receive a placebo
N/AProducts
Cipro IV (Ciprofloxacin, BAYQ3939)Accepts Healthy Volunteer
N/ATrial design
Trial Type
InterventionalIntervention Type
N/ATrial Purpose
N/AAllocation
N/ABlinding
N/AAssignment
N/ATrial Arms
N/A